kathleen a. stringer, pharmd
Professor, Clinical Pharmacy
Dr. Stringer is a Professor of Clinical Pharmacy in the Department of Clinical Sciences, College of Pharmacy at the University of Michigan. She received her PharmD degree from the University of Michigan, completed a residency in pharmacy practice at the University of Illinois Chicago, and a fellowship in cardiovascular pharmacotherapy at the State University of New York at Buffalo. She also completed a mid-career fellowship pulmonary research at the University of Colorado Health Sciences Center, Webb Waring Institute for Antioxidant Research. Dr. Stringer was a member of the School of Pharmacy faculty at the University of Colorado Health Sciences Center in Denver from 1988-2007; she joined the College of Pharmacy faculty at the University of Michigan in 2007. Since joining the University of Michigan faculty, Dr. Stringer has secured National Institutes of Health funding to support her work in pulmonary drug delivery and drug development. She also has developed an emerging program in clinical metabolomics and serves as a mentor on the NIH/NHLBI T32 Multidisciplinary Training Program in Lung Diseases.
Dr. Stringer’s research focuses on prognostic biomarker and drug target discovery using nuclear magnetic resonance (NMR) and liquid-chromatography-mass-spectroscopy (LC-MS)-based untargeted and targeted metabolomics. She is also using pharmacometabolomics to search for predictive biomarkers of drug response. Her effort is aimed at unraveling the complexity and characterizing the treatment responses of fibrin-inflammatory illnesses including acute respiratory distress syndrome, deep vein thrombosis and the rare, most often pediatric disease, plastic bronchitis.